SBRI Healthcare
VC Fund
Cambridge, United Kingdom
SBRI Healthcare is a VC fund in Cambridge focused on Health Care and Medical. Accelerating the develpoment of new technologies that meet the needs of the NHS. An NHS England initiative delivered by the AHSN Network.
- Total investments:
- 202
- Last investment:
- Lead investor:
- 87%
Last updated:
For AI agents: llms.txt
Industries SBRI Healthcare invests in
Stages SBRI Healthcare invests in
Countries SBRI Healthcare invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Wendy Tindale
|
|||
Investment Focus
Industry
- Health Care 118 (58%)
- Medical 44 (22%)
- Software 32 (16%)
- Medical Device 32 (16%)
- Biotechnology 21 (10%)
Stage
- Grant 165 (82%)
- Funding Round 1 (0%)
- Non-equity Assistance 1 (0%)
Country
- United Kingdom 151 (75%)
- United States 8 (4%)
- Ireland 2 (1%)
- India 1 (0%)
- Spain 1 (0%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wendy Tindale
Panel Chair
|
Panel Chair | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Pockit has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. Biomarkers enable faster and more accurate stroke diagnosis which will decrease the time to treatment, reducing disabilities and deaths after a stroke. Pockit owns a family of patents which protects novelbiomarkers for stroke detection. | Grant / May 12, 2025 | |
|
|
Presymptom Health develops a portfolio of clinical decision support algorithms and blood tests to enable early intervention and transform critical care outcomes. | $251.9K / Grant / Feb 27, 2025 | |
|
|
Little Journey offers assistance to kids and their families who are getting medical treatments or taking part in scientific trials. The company was founded in 2018. | $2.6M / Grant / Nov 18, 2024 | |
|
|
The Sixth Sense in medical Diagnostics.At AINOSTICS we are working to identify the earliest biological signs of some of our society’s most devastating neurodegenerative conditions such as Alzheimer’s disease, Huntington's and MS, providing the best chance of success in the development of potential preventions and therapeutics by Pharma, andprecise treatment planning by clinicians.We combine the most exciting medical imaging innovations with the best of artificial intelligence solutions to unlock the future of personalised diagnosis, prognosis, and therapy monitoring and planning. | $1.5M / Grant / May 01, 2024 | |
|
|
Damibu Ltd is a technology company specialising in innovative digital solutions, particularly for healthcare and public sector organisations. They focus on creating platforms that simplify content management and distribution, enhancing communication efficiency. Notably, their product Damibu Feeds aids NHS groups in the UK by automating contentsharing among GP surgeries, saving time and resources. Their approach emphasises user-friendly designs and interoperability, ensuring seamless integration with existing systems. Damibu's commitment to improving digital health communication is evident in their solutions, which aim to streamline processes, ensure content accuracy, and enhance patient engagement through reliable and accessible information dissemination. | $634K / Grant / Jan 31, 2024 | |
|
|
E Moodie is a mental health digital platform. | $125.9K / Grant / Sep 01, 2023 | |
|
|
iPLATO is the developer of myGP - a patient engagement platform that simplifies access to healthcare | $2.1M / Grant / Apr 28, 2023 | |
|
|
Pockit has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. Biomarkers enable faster and more accurate stroke diagnosis which will decrease the time to treatment, reducing disabilities and deaths after a stroke. Pockit owns a family of patents which protects novelbiomarkers for stroke detection. | $985.2K / Grant / Jan 24, 2023 | |
|
|
Tiny Medical Apps taking essential asthma information off the page and onto young people's smartphones.Learnable for Asthma Engaging young people in their Personalised Asthma Action Plans with our Gamified PlatformToday two-thirds of deaths caused by asthma in the UK are preventable. That means hundreds of people, especially teenagers,are dying needlessly each year. There’s already a solution out there. Personalised Asthma Action Plans (PAAP) offer practical information on how young people can manage their condition. Despite the fact that having a PAAP means they’re four times less likely to end up in hospital, only 30% have them, and many don’t understand how they work.Tiny Medical Apps’ Learnable system puts the PAAP into teenagers’ pockets by reinventing the information as a fun app for their smartphones. | Grant / Jan 18, 2023 | |
|
|
Discover Momenta provides evidence-based behavioural healthy lifestyle solutions to the communities | $603.4K / Grant / Jan 17, 2023 | |
| See all 202 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does SBRI Healthcare invest in?
SBRI Healthcare invests primarily in Health Care, Medical and Software startups, most often at Grant and Funding Round stage. Most of the 202 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact SBRI Healthcare?
Public channels for SBRI Healthcare include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at SBRI Healthcare?
The team at SBRI Healthcare includes Wendy Tindale (Panel Chair). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!